Search

The UK is to back up a review of science and innovation policy by former science minister David Sainsbury with £1 billion over the next three years to boost business innovation and technology development.

The Green Paper on the formation of a European Research Area attracted more than 800 responses by the time the consultation came to an end this week.

The European Commission wants to remove the stigma of bankruptcy and give entrepreneurs a second chance.

Biotech and pharma companies have overtaken the technology sector in the European Commission’s annual scoreboard of R&D investment for the first time.

With the French Senate ratifying the London Agreement on patent translation, technology companies can look to a much cheaper future.

Economic impact must be embedded into research policy, says Philip Esler, Chief Executive of the UK’s Arts and Humanities and Research Council.

Flagship venture capitalist David Berry takes a hands-on approach to finding and nurturing emerging ideas and companies in life sciences and clean energy.

A major survey shows confidence holding steady as early-stage funding eases slightly – and the relationship with big pharma improves.

PepsiCo’s $5.2 million donation to look at lifestyle and chronic disease looks like an act of the archest cynicism. But someone needs to do something, says Nuala Moran.

New findings strengthen concerns that the European Clinical Trials Directive has hampered academic clinical research.